These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32355752)

  • 1. Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients.
    Dong K; Zhang Y; Huang JJ; Xia SS; Yang Y
    Ann Transl Med; 2020 Mar; 8(6):308. PubMed ID: 32355752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Zhang M; Hu ML; Huang JJ; Xia SS; Yang Y; Dong K
    Chin Med J (Engl); 2019 Dec; 132(24):2927-2933. PubMed ID: 31809318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
    Kim D; Li AA; Ahmed A
    Liver Int; 2018 Oct; 38(10):1839-1848. PubMed ID: 29797393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus.
    Peng X; Huang J; Xia S; Yang Y; Dong K
    J Res Med Sci; 2021; 26():43. PubMed ID: 34484375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study.
    Korkiakoski A; Käräjämäki AJ; Ronkainen J; Auvinen J; Hannuksela J; Kesäniemi YA; Ukkola O
    Scand J Clin Lab Invest; 2022 May; 82(3):173-180. PubMed ID: 35416741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
    Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
    Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiogram QRS duration and associations with telomere length: A cross-sectional analysis in Australian rural diabetic and non-diabetic population.
    Zhou Y; Jelinek H; Hambly BD; McLachlan CS
    J Electrocardiol; 2017; 50(4):450-456. PubMed ID: 28249683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
    Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
    J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK; Marella HK; Jiang Y; Ganguli S; Snell P; Podila PSB; Maliakkal B; Satapathy SK
    J Clin Exp Hepatol; 2020; 10(3):245-254. PubMed ID: 32405181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.
    Alam MS; Kamrul-Hasan ABM; Kalam ST; Rahman SMM; Hoque MI; Islam MB; Paul AK
    Diabetes Metab Syndr Obes; 2021; 14():3089-3096. PubMed ID: 34262313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
    Xiu L; Jiang T; Yao XA; Wen Z
    Int J Gen Med; 2021; 14():3099-3107. PubMed ID: 34234538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortening of the leucocytes' telomeres length in T2DM independent of age and telomerase activity.
    AlDehaini DMB; Al-Bustan SA; Ali ME; Malalla ZHA; Sater M; Giha HA
    Acta Diabetol; 2020 Nov; 57(11):1287-1295. PubMed ID: 32500358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study.
    Mikolasevic I; Domislovic V; Turk Wensveen T; Delija B; Klapan M; Juric T; Lukic A; Mijic A; Skenderevic N; Puz P; Ostojic A; Krznaric Z; Radic-Kristo D; Filipec Kanizaj T; Stimac D
    Eur J Intern Med; 2020 Dec; 82():68-75. PubMed ID: 32839076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shortening of leukocyte telomere length relates to DNA hypermethylation of LINE-1 in type 2 diabetes mellitus.
    Wu Y; Cui W; Zhang D; Wu W; Yang Z
    Oncotarget; 2017 Sep; 8(43):73964-73973. PubMed ID: 29088760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin treatment affects leukocyte telomere length in patients with type 2 diabetes: 6-year longitudinal study.
    Zeng JB; Liu HB; Ping F; Li W; Li YX
    J Diabetes Complications; 2019 May; 33(5):363-367. PubMed ID: 30857946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shorter leukocyte telomere length protects against NAFLD progression in children.
    Wojcicki JM; Gill RM; Wilson L; Lin J; Rosenthal P
    Sci Rep; 2023 Apr; 13(1):5446. PubMed ID: 37012261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte telomere length and mortality risk in patients with type 2 diabetes.
    Bonfigli AR; Spazzafumo L; Prattichizzo F; Bonafè M; Mensà E; Micolucci L; Giuliani A; Fabbietti P; Testa R; Boemi M; Lattanzio F; Olivieri F
    Oncotarget; 2016 Aug; 7(32):50835-50844. PubMed ID: 27437767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.